Fluorine-18 is the most frequently used radioisotope in positron emission tomography (PET)
radiopharmaceuticals in both clinical and preclinical research. Its physical and nuclear …

Context In patients treated for prostate cancer, a rising serum prostate-specific antigen (PSA)
level is a first sign of relapse, but imaging is needed to determine the localization of the …

The aim was to develop clinical guidelines for multi-parametric MRI of the prostate by a
group of prostate MRI experts from the European Society of Urogenital Radiology (ESUR) …

CONTEXT: The role of positron emission tomography (PET) and PET/computed tomography
(PET/CT) in prostate cancer (PCa) imaging is still debated, although guidelines for their use …

OBJECTIVE. This article is a primer on the technical aspects of performing a high-quality
dynamic contrast-enhanced MRI (DCE-MRI) examination of the prostate gland …

Context Radiolabelled choline positron emission tomography has changed the
management of prostate cancer patients. However, new emerging radiopharmaceutical …

Imaging has traditionally played a minor role in the diagnosis and staging of prostate cancer.
However, recent controversies generated by the use of prostate‐specific antigen (PSA) …

The aim of this study was to compare 11C-choline PET/CT with pelvic multiparametric MR
imaging for detection of recurrent prostate carcinoma in patients with suspected recurrence …

Aim The increase of prostate-specific antigen (PSA) after radical retropubic prostatectomy
(RP) or external beam radiotherapy (EBRT) is the most sensitive tool for detecting prostate …

Background Diagnosing the biochemical recurrence (BCR) of prostate cancer (PCa) is a
clinical challenge, and early detection of BCR can help patients receive optimal treatment …